Pacific Biosciences of California Inc. buy Zacks Research
Start price
21.02.26
/
50%
€1.34
Target price
21.02.27
-
Performance (%)
-17.61%
Price
13.03.26
€1.16
Summary
This prediction is currently active. The prediction for Pacific Biosciences of California Inc. disappoints with a performance of -17.61%. This prediction currently runs until 21.02.27. The prediction end date can be changed by Zacks_Research at any time. Zacks_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Pacific Biosciences of California Inc. | -1.992% |
| iShares Core DAX® | -1.104% |
| iShares Nasdaq 100 | 0.328% |
| iShares Nikkei 225® | -1.082% |
| iShares S&P 500 | -0.055% |
Comments by Zacks_Research for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California (NASDAQ:PACB) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for PACB provided by MarketBeat